LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 25

Search options

  1. Book ; Online ; E-Book: Oxford handbook of respiratory nursing

    Scullion, Jane / Robinson, Terry E.

    (Oxford handbooks in nursing)

    2021  

    Abstract: This handbook gives a systematic account of the main respiratory diseases in adults, covering assessment, diagnosis and nursing management. It highlights the multiple needs of respiratory patients - not only the physical requirements but also ... ...

    Author's details edited by Terry Robinson, Jane E. Scullion
    Series title Oxford handbooks in nursing
    Abstract This handbook gives a systematic account of the main respiratory diseases in adults, covering assessment, diagnosis and nursing management. It highlights the multiple needs of respiratory patients - not only the physical requirements but also psychosocial needs, including palliative care and end of life issues.
    Keywords Respiratory organs/Diseases/Nursing
    Subject code 616.2004231
    Language English
    Size 1 online resource (656 pages) :, illustrations (black and white, and colour).
    Edition Second edition.
    Publisher Oxford University Press
    Publishing place Oxford
    Document type Book ; Online ; E-Book
    Note This edition also issued in print: 2021.
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 0-19-256772-1 ; 0-19-256771-3 ; 0-19-188658-0 ; 0-19-883181-1 ; 978-0-19-256772-7 ; 978-0-19-256771-0 ; 978-0-19-188658-4 ; 978-0-19-883181-5
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article: COPD: should we go for GOLD?

    Scullion, Jane E

    British journal of nursing (Mark Allen Publishing)

    2015  Volume 24, Issue 20, Page(s) 1024–1025

    MeSH term(s) Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/therapeutic use ; Adrenergic beta-Agonists/administration & dosage ; Adrenergic beta-Agonists/therapeutic use ; Drug Therapy, Combination ; Humans ; Muscarinic Antagonists/administration & dosage ; Muscarinic Antagonists/therapeutic use ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Pulmonary Disease, Chronic Obstructive/pathology ; United Kingdom
    Chemical Substances Adrenal Cortex Hormones ; Adrenergic beta-Agonists ; Muscarinic Antagonists
    Language English
    Publishing date 2015-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 1119191-0
    ISSN 0966-0461
    ISSN 0966-0461
    DOI 10.12968/bjon.2015.24.20.1024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers.

    Keeley, Duncan / Scullion, Jane E / Usmani, Omar S

    The European respiratory journal

    2020  Volume 55, Issue 5

    MeSH term(s) Administration, Inhalation ; Carbon ; Humans ; Nebulizers and Vaporizers
    Chemical Substances Carbon (7440-44-0)
    Keywords covid19
    Language English
    Publishing date 2020-05-27
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.01122-2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers.

    Keeley, Duncan / Scullion, Jane E / Usmani, Omar S

    The European respiratory journal

    2020  Volume 55, Issue 2

    MeSH term(s) Administration, Inhalation ; Bronchodilator Agents ; Carbon ; Environment ; Humans ; Metered Dose Inhalers ; Nebulizers and Vaporizers ; Policy
    Chemical Substances Bronchodilator Agents ; Carbon (7440-44-0)
    Language English
    Publishing date 2020-02-27
    Publishing country England
    Document type Editorial
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.00048-2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Pregnancy, childbirth and neonatal outcomes of women with rare inherited coagulation disorders.

    McCann, Lucy Jane / Scullion, Erin / Doy, Lauren / Ciantar, Etienne

    Obstetric medicine

    2023  Volume 16, Issue 4, Page(s) 222–227

    Abstract: Background: We aimed to describe the characteristics and the pregnancy outcomes of women with rare inherited coagulation factor disorders managed at a tertiary obstetric-haematology unit in the United Kingdom.: Methods: A retrospective service ... ...

    Abstract Background: We aimed to describe the characteristics and the pregnancy outcomes of women with rare inherited coagulation factor disorders managed at a tertiary obstetric-haematology unit in the United Kingdom.
    Methods: A retrospective service evaluation was conducted using routinely collected medical records. Descriptive analyses were applied to investigate pregnancy, childbirth and neonatal management and outcomes.
    Results: Overall, 20 patients with rare inherited coagulation disorders were included who birthed 30 live infants from 29 pregnancies. Regarding maternal bleeding outcomes, 3% experienced antepartum haemorrhage, 38% of pregnancies experienced primary post-partum haemorrhage, and none experienced secondary post-partum haemorrhage. Five (17%) neonates had cranial ultrasound scans for imaging to investigate for a neonatal haemorrhage, which were all normal.
    Conclusions: Although women with rare inherited coagulation disorders may be more susceptible to complications in pregnancy, within this cohort there was no evidence that the condition led to increased morbidity or mortality when best practices were observed.
    Language English
    Publishing date 2023-01-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2612229-7
    ISSN 1753-4968 ; 1753-495X
    ISSN (online) 1753-4968
    ISSN 1753-495X
    DOI 10.1177/1753495X221148813
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Erectile dysfunction in COPD: A hidden co-morbidity.

    Scullion, Jane E / Vincent, Emma

    Chronic respiratory disease

    2016  Volume 13, Issue 1, Page(s) 3–4

    MeSH term(s) Erectile Dysfunction/complications ; Humans ; Male ; Pulmonary Disease, Chronic Obstructive/complications
    Language English
    Publishing date 2016-02
    Publishing country England
    Document type Editorial
    ZDB-ID 2211488-9
    ISSN 1479-9731 ; 1479-9723
    ISSN (online) 1479-9731
    ISSN 1479-9723
    DOI 10.1177/1479972315616932
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Nurse to nurse palliative care Margaret L Campbell Nurse to nurse palliative care McGraw Hill £21.99 304pp 9780071493239 9780071493239 [Formula: see text].

    Scullion, Jane E

    Nursing older people

    2010  Volume 22, Issue 2, Page(s) 11

    Abstract: This is a timely book covering conditions other than cancer. intended for hospital nurses to enhance previous training and/ or experience, it does this through facts, questions, case studies and clinical alerts. it contains a useful list of acronyms, ... ...

    Abstract This is a timely book covering conditions other than cancer. intended for hospital nurses to enhance previous training and/ or experience, it does this through facts, questions, case studies and clinical alerts. it contains a useful list of acronyms, references and web links as well as a full-text personal digital assistant download. The discussion on withdrawing devices and interventions and a ventilator withdrawal algorithm are useful. Although written for the American market, there are many lessons for the UK.
    Language English
    Publishing date 2010-03-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2028615-6
    ISSN 2047-8941 ; 1472-0795
    ISSN (online) 2047-8941
    ISSN 1472-0795
    DOI 10.7748/nop.22.2.11.s16
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations.

    Miravitlles, Marc / Bhutani, Mohit / Hurst, John R / Franssen, Frits M E / van Boven, Job F M / Khoo, Ee Ming / Zhang, Jing / Brunton, Stephen / Stolz, Daiana / Winders, Tonya / Asai, Kazuhisa / Scullion, Jane E

    Advances in therapy

    2023  Volume 40, Issue 10, Page(s) 4236–4263

    Abstract: Discharge bundles, comprising evidence-based practices to be implemented prior to discharge, aim to optimise patient outcomes. They have been recommended to address high readmission rates in patients who have been hospitalised for an exacerbation of ... ...

    Abstract Discharge bundles, comprising evidence-based practices to be implemented prior to discharge, aim to optimise patient outcomes. They have been recommended to address high readmission rates in patients who have been hospitalised for an exacerbation of chronic obstructive pulmonary disease (COPD). Hospital readmission is associated with increased morbidity and healthcare resource utilisation, contributing substantially to the economic burden of COPD. Previous studies suggest that COPD discharge bundles may result in fewer hospital readmissions, lower risk of mortality and improvement of patient quality of life. However, evidence for their effectiveness is inconsistent, likely owing to variable content and implementation of these bundles. To ensure consistent provision of high-quality care for patients hospitalised with an exacerbation of COPD and reduce readmission rates following discharge, we propose a comprehensive discharge protocol, and provide evidence highlighting the importance of each element of the protocol. We then review care bundles used in COPD and other disease areas to understand how they affect patient outcomes, the barriers to implementing these bundles and what strategies have been used in other disease areas to overcome these barriers. We identified four evidence-based care bundle items for review prior to a patient's discharge from hospital, including (1) smoking cessation and assessment of environmental exposures, (2) treatment optimisation, (3) pulmonary rehabilitation, and (4) continuity of care. Resource constraints, lack of staff engagement and knowledge, and complexity of the COPD population were some of the key barriers inhibiting effective bundle implementation. These barriers can be addressed by applying learnings on successful bundle implementation from other disease areas, such as healthcare practitioner education and audit and feedback. By utilising the relevant implementation strategies, discharge bundles can be more (cost-)effectively delivered to improve patient outcomes, reduce readmission rates and ensure continuity of care for patients who have been discharged from hospital following a COPD exacerbation.
    MeSH term(s) Humans ; Patient Discharge ; Quality of Life ; Patient Readmission ; Hospitals ; Pulmonary Disease, Chronic Obstructive/therapy
    Language English
    Publishing date 2023-08-04
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 632651-1
    ISSN 1865-8652 ; 0741-238X
    ISSN (online) 1865-8652
    ISSN 0741-238X
    DOI 10.1007/s12325-023-02609-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The development of anticholinergics in the management of COPD.

    Scullion, Jane E

    International journal of chronic obstructive pulmonary disease

    2007  Volume 2, Issue 1, Page(s) 33–40

    Abstract: Anticholinergics have been used to treat obstructive respiratory disease for many years from historical preparations of the deadly nightshade genus, to the more recent developments ofipratropium, oxitropium, and tiotropium. The medical treatment of ... ...

    Abstract Anticholinergics have been used to treat obstructive respiratory disease for many years from historical preparations of the deadly nightshade genus, to the more recent developments ofipratropium, oxitropium, and tiotropium. The medical treatment of airways obstruction has focused on achieving maximal airway function through bronchodilators. Of the two main bronchodilators, beta2-agonists are often the first treatment choice although there is evidence of equivalence and some suggestions of the superiority of anticholinergics in chronic obstructive pulmonary disease (COPD). The following review looks at the background of anticholinergics, their pharmacological properties, and the evidence for use with suggestions for their place in the treatment of COPD.
    MeSH term(s) Cholinergic Antagonists/pharmacokinetics ; Cholinergic Antagonists/pharmacology ; Cholinergic Antagonists/therapeutic use ; Exercise Tolerance ; Humans ; Ipratropium/therapeutic use ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Pulmonary Disease, Chronic Obstructive/psychology ; Quality of Life ; Receptor, Muscarinic M1/antagonists & inhibitors ; Receptor, Muscarinic M2/antagonists & inhibitors ; Receptor, Muscarinic M3/antagonists & inhibitors ; Scopolamine Derivatives/therapeutic use ; Tiotropium Bromide
    Chemical Substances Cholinergic Antagonists ; Receptor, Muscarinic M1 ; Receptor, Muscarinic M2 ; Receptor, Muscarinic M3 ; Scopolamine Derivatives ; oxitropium (8G15T83E6I) ; Ipratropium (GR88G0I6UL) ; Tiotropium Bromide (XX112XZP0J)
    Language English
    Publishing date 2007-11-14
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2212419-6
    ISSN 1178-2005 ; 1176-9106
    ISSN (online) 1178-2005
    ISSN 1176-9106
    DOI 10.2147/copd.2007.2.1.33
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Predicting fracture risk in patients with chronic obstructive pulmonary disease: a UK-based population-based cohort study.

    Akyea, Ralph Kwame / McKeever, Tricia M / Gibson, Jack / Scullion, Jane E / Bolton, Charlotte E

    BMJ open

    2019  Volume 9, Issue 4, Page(s) e024951

    Abstract: Objective: To assess the incidence of hip fracture and all major osteoporotic fractures (MOF) in patients with chronic obstructive pulmonary disease (COPD) compared with non-COPD patients and to evaluate the use and performance of fracture risk ... ...

    Abstract Objective: To assess the incidence of hip fracture and all major osteoporotic fractures (MOF) in patients with chronic obstructive pulmonary disease (COPD) compared with non-COPD patients and to evaluate the use and performance of fracture risk prediction tools in patients with COPD. To assess the prevalence and incidence of osteoporosis.
    Design: Population-based cohort study.
    Setting: UK General Practice health records from The Health Improvement Network database.
    Participants: Patients with an incident COPD diagnosis from 2004 to 2015 and non-COPD patients matched by age, sex and general practice were studied.
    Outcomes: Incidence of fracture (hip alone and all MOF); accuracy of fracture risk prediction tools in COPD; and prevalence and incidence of coded osteoporosis.
    Methods: Cox proportional hazards models were used to assess the incidence rates of osteoporosis, hip fracture and MOF (hip, proximal humerus, forearm and clinical vertebral fractures). The discriminatory accuracies (area under the receiver operating characteristic [ROC] curve) of fracture risk prediction tools (FRAX and QFracture) in COPD were assessed.
    Results: Patients with COPD (n=80 874) were at an increased risk of fracture (both hip alone and all MOF) compared with non-COPD patients (n=308 999), but this was largely mediated through oral corticosteroid use, body mass index and smoking. Retrospectively calculated ROC values for MOF in COPD were as follows: FRAX: 71.4% (95% CI 70.6% to 72.2%), QFracture: 61.4% (95% CI 60.5% to 62.3%) and for hip fracture alone, both 76.1% (95% CI 74.9% to 77.2%). Prevalence of coded osteoporosis was greater for patients (5.7%) compared with non-COPD patients (3.9%), p<0.001. The incidence of osteoporosis was increased in patients with COPD (n=73 084) compared with non-COPD patients (n=264 544) (adjusted hazard ratio, 1.13, 95% CI 1.05 to 1.22).
    Conclusion: Patients with COPD are at an increased risk of fractures and osteoporosis. Despite this, there is no systematic assessment of fracture risk in clinical practice. Fracture risk tools identify those at high risk of fracture in patients with COPD.
    MeSH term(s) Adrenal Cortex Hormones/adverse effects ; Adrenal Cortex Hormones/therapeutic use ; Aged ; Female ; Humans ; Male ; Middle Aged ; Osteoporotic Fractures/chemically induced ; Osteoporotic Fractures/epidemiology ; Osteoporotic Fractures/physiopathology ; Proportional Hazards Models ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Pulmonary Disease, Chronic Obstructive/physiopathology ; ROC Curve ; Retrospective Studies ; Risk Assessment ; Risk Factors ; United Kingdom/epidemiology
    Chemical Substances Adrenal Cortex Hormones
    Language English
    Publishing date 2019-04-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2747269-3
    ISSN 2044-6055 ; 2044-6055 ; 2053-3624
    ISSN (online) 2044-6055
    ISSN 2044-6055 ; 2053-3624
    DOI 10.1136/bmjopen-2018-024951
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top